Skip to main content
SpringerLink
Log in
Book cover

Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy

  • Conference proceedings
  • © 1991

Overview

Editors:
  1. P. Banzet

    1. Hôpital Saint-Louis, Paris Cedex 10, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. J. F. Holland

    1. The Mount Sinai Medical Center, New York, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. D. Khayat

    1. Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière, Paris Cedex 13, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. M. Weil

    1. Hôpital Pitié-Salpétrière, Paris Cedex 13, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (116 papers)

  1. Front Matter

    Pages I-XV
    Download chapter PDF

  2. The first Claude Jacquillat Memorial Lecture : Chemotherapy of cancer

    1. The first Claude Jacquillat Memorial Lecture : Chemotherapy of cancer

      • J. F. Holland
      Pages 1-10

  3. Head and neck

    1. Front Matter

      Pages 11-11
      Download chapter PDF

    2. Neo-Adjuvant chemotherapy for patients with oral and oro-pharyngeal T3/T4 carcinomas

      • H. Szpirglas, D. Nizri, J. P. Lacoste, A. Thomas, S. Godeau, L. Benslama
      Pages 13-17

    3. Induction chemotherapy with Cisplatin and 5-FU for squamous cell carcinoma of the head and neck. Six years experience at the Nice Cancer Center

      • M. Schneider, F. Demard, P. Chauvel, A. Thyss, M. H. Gaspard, J. Santini et al.
      Pages 18-22

    4. Neo-Adjuvant chemotherapy for organ preservation with high dose continuous infusion of Cisplatin, 5-Fluorouracil, and Mitoguazone for head and neck cancer : a preliminary report

      • Susan Urba, A. Forastiere, G. Wolf, A. Thornton
      Pages 23-24

    5. Significance of tumour site in assessing survival benefit of Neo-Adjuvant chemotherapy in advanced head and neck cancer : a lack of survival advantage in patients with oral cavity tumours despite achieving a high clinical complete remission rate after local therapy

      • B. T. Hill, L. A. Price
      Pages 25-27

    6. Preservation of the larynx following Neo-Adjuvant chemotherapy. A preliminary report

      • O. Laccourreye, V. Bassot, M. Menard, D. Brasnu, H. Laccourreye
      Pages 28-31

    7. Selection of radiocurable head and neck cancers by Neo-Adjuvant chemotherapy response

      • J. M. Deneufbourg
      Pages 32-34

    8. Neo-Adjuvant chemotherapy with Cisplatin and 5-Fluorouracil, both in continuous 96 hours perfusion, in the multidisciplinary treatment of locally advanced head and neck cancer

      • E. Fonseca, J. J. Cruz, A. Gómez, P. Sánchez, G. Martin, P. Santos et al.
      Pages 35-37

    9. Organ preservation in the treatment of hypopharyngeal squamous cell carcinoma. Preliminary results of a randomized trial

      • J. L. Lefebvre, L. Adenis, D. Chevalier, B. Castelain, J. van Ton, J. Stern et al.
      Pages 38-40

    10. Regional control after induction chemotherapy for advanced squamous cell carcinoma of the head and neck (SCCHN): a retrospective analysis of 303 patients

      • P. Busse, J. Clark, C. Norris Jr, A. Dreyfuss, C. Beard, J. Lucarini et al.
      Pages 41-44

    11. Exclusive chemotherapy in head and neck cancer

      • V. Bassot, P. Bonfils, O. Laccourreye, E. Chabardes, M. Menard, D. Brasnu et al.
      Pages 45-49

    12. Neo-Adjuvant Cisplatin, 5-Fluorouracil and high-dose Leucovorin for advanced head and neck cancer : response, toxicity, survival and comparison with historical controls

      • J. Clark, A. Dreyfuss, C. Norris Jr, P. Busse, C. Beard, J. Lucarini et al.
      Pages 50-53

    13. 5-Fluorouracil modulation in head and neck cancer

      • E. E. Vokes, W. R. Panje, R. R. Weichselbaum
      Pages 54-57

    14. Cisplatin, 5-Fluorouracil and high dose oral Leucovorin (PFL) with Methotrexate and Piritrexim as Neo-Adjuvant chemotherapy for head and neck cancer

      • Everett E. Vokes, D. J. Haraf, W. R. Panje, J.-M. McEvilly, M. F. Kozloff, D. Goldman et al.
      Pages 58-60

    15. Efficacy of concomitant chemoradiotherapy in poor prognosis head and neck cancer

      • Daniel J. Haraf, E. E. Vokes, W. R. Panje, R. R. Weichselbaum
      Pages 61-65

    16. Radiotherapy (RT) with concomitant Cisplatin (CDDP) in the management of locally advanced or recurrent head and neck cancer (LARHNC)

      • G. Gasparini, S. Dal Fior, G. Recher, G. Panizzoni, V. Cristoferi, A. Testolin et al.
      Pages 66-68

    17. Primary chemotherapy and surgery in advanced oral cavity squamous cell carcinomas : retrospective analysis

      • L. Licitra, C. Grandi, V. Bonfante, M. I. Grosso, M. Guzzo, R. Molinari et al.
      Pages 69-70

    18. Neo-Adjuvant intra-arterial chemotherapy by Cisplatin and 5-FU for squamous cell carcinoma of the oral cavity

      • M. H. Gaspard, J. Santini, O. Dassonville, A. Thyss, F. Demard, M. Schneider
      Pages 71-75
Back to top

Keywords

About this book

This book includes some selected presentations given at the 3rd International Congress on Neo-Adjuvant Chemotherapy which was held in Paris from February 6th to February 9th, 1991. It was attended by over 2000 physicians from around the world and by 700 nurses. Its organisation was saddened by the untimely death of Professor Claude Jacquillat on October 12th, 1990. It was further complicated in January and February 1991 by the gulf events which led some guests to cancel their participation. However with the outstanding help of the two presidents cho­ sen by Claude Jacquillat before his death, Pierre Banzet from Paris and James F. Holland from New York, the organizers could set up an exciting meeting confirming the impact of neo-adjuvant chemotherapy on relatively new indi­ cations such as non-small lung cancers, bladder cancer, esophagal cancer, cer­ vix cancer, etc ... It is noteworthy that a contradictory debate on primary chemotherapy in non-small lung cancer turned into a consensus conference. In breast cancer, the downstaging induced by primary chemotherapy is ack­ nowledged by all and the conviction that Jacquillat defended so heartily that breast preservation should be proposed to all patients with breast cancer what­ ever their tumour size is shared now by more and more people. A special emphasis was given to new drugs, new combination, new access (locoregional therapy) and new developments such as that of growth factors and of interleukin 2.

Editors and Affiliations

  • Hôpital Saint-Louis, Paris Cedex 10, France

    P. Banzet

  • The Mount Sinai Medical Center, New York, USA

    J. F. Holland

  • Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière, Paris Cedex 13, France

    D. Khayat

  • Hôpital Pitié-Salpétrière, Paris Cedex 13, France

    M. Weil

Bibliographic Information

  • Book Title: Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy

  • Editors: P. Banzet, J. F. Holland, D. Khayat, M. Weil

  • DOI: https://doi.org/10.1007/978-2-8178-0782-9

  • Publisher: Springer Paris

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag France 1991

  • Softcover ISBN: 978-2-8178-0784-3Published: 11 April 2014

  • eBook ISBN: 978-2-8178-0782-9Published: 29 June 2013

  • Edition Number: 1

  • Number of Pages: XV, 483

  • Number of Illustrations: 88 b/w illustrations, 6 illustrations in colour

  • Additional Information: ISBN für Springer-Verlag France: 2-287-00347-9

  • Topics: Oncology, Pharmacology/Toxicology, Otorhinolaryngology, Neurology, Neuroradiology

Publish with us

Policies and ethics

Back to top

Search

Navigation